Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage
Yuqian Li,1,* Wei Fang,1,* Lei Tao,2,* Min Li,1 Yanlong Yang,1 Yafei Gao,1 Shunnan Ge,1 Li Gao,1 Bin Zhang,1 Zhihong Li,1 Wei Zhou,1 Boliang Wang,3 Lihong Li11Department of Neurosurgery, 2Department of Anesthesiology, 3Department of Emergency, Tangdu Hospital, The Fourth Military Medical University,...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/eac07ed38a054824be62e6d2a287f0e9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:eac07ed38a054824be62e6d2a287f0e9 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:eac07ed38a054824be62e6d2a287f0e92021-12-02T01:27:19ZEfficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage1178-2021https://doaj.org/article/eac07ed38a054824be62e6d2a287f0e92015-05-01T00:00:00Zhttp://www.dovepress.com/efficacy-and-safety-of-intravenous-nimodipine-administration-for-treat-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Yuqian Li,1,* Wei Fang,1,* Lei Tao,2,* Min Li,1 Yanlong Yang,1 Yafei Gao,1 Shunnan Ge,1 Li Gao,1 Bin Zhang,1 Zhihong Li,1 Wei Zhou,1 Boliang Wang,3 Lihong Li11Department of Neurosurgery, 2Department of Anesthesiology, 3Department of Emergency, Tangdu Hospital, The Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China*These authors contributed equally to this studyBackground: Nicardipine (NC) is the most commonly used antihypertensive drug in neurological patients with hypertension. Although nimodipine (NM) is widely used to treat cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage, trials exploring its antihypertensive effect after intravenous administration in subjects with intracerebral hemorrhage (ICH) are scarce.Methods: A retrospective study was carried out to compare the safety and efficacy of NC and NM administered intravenously in patients with ICH. Therapeutic responses were assessed by achievement of goal blood pressure (BP); use of additional medications for BP control; proportion of time spent within goal; variability in BP; time to goal BP; number of dose adjustments; variability in ICH volume, Glasgow Coma Scale score, and intracranial pressure; and drug-related complications.Results: A total of 87 patients were eligible for analysis (n=46 [NC]; n=41 [NM]), and baseline characteristics between groups were similar. Both agents were effective in achieving goal BP during infusion, with 93.5% and 87.8% patients in the NC and NM groups achieving goal, respectively. Fewer additional medications were needed to control BP in the NC group. BP variability was similar and no differences were observed in the mean time to goal BP and mean numbers of dose adjustments between both groups. Interestingly, intracranial pressure declined (P=0.048) during NC administration but increased (P=0.066) after NM treatment. Finally, the incidences of hematoma expansion, neurological deterioration, and adverse drug events were similar in both groups.Conclusion: NM is effective and safe for BP control in patients with ICH.Keywords: nicardipine, blood pressure, intravenous infusionLi YQFang WTao LLi MYang YLGao YFGe SNGao LZhang BLi ZHZhou WWang BLLi LHDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 1231-1238 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Li YQ Fang W Tao L Li M Yang YL Gao YF Ge SN Gao L Zhang B Li ZH Zhou W Wang BL Li LH Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| description |
Yuqian Li,1,* Wei Fang,1,* Lei Tao,2,* Min Li,1 Yanlong Yang,1 Yafei Gao,1 Shunnan Ge,1 Li Gao,1 Bin Zhang,1 Zhihong Li,1 Wei Zhou,1 Boliang Wang,3 Lihong Li11Department of Neurosurgery, 2Department of Anesthesiology, 3Department of Emergency, Tangdu Hospital, The Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China*These authors contributed equally to this studyBackground: Nicardipine (NC) is the most commonly used antihypertensive drug in neurological patients with hypertension. Although nimodipine (NM) is widely used to treat cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage, trials exploring its antihypertensive effect after intravenous administration in subjects with intracerebral hemorrhage (ICH) are scarce.Methods: A retrospective study was carried out to compare the safety and efficacy of NC and NM administered intravenously in patients with ICH. Therapeutic responses were assessed by achievement of goal blood pressure (BP); use of additional medications for BP control; proportion of time spent within goal; variability in BP; time to goal BP; number of dose adjustments; variability in ICH volume, Glasgow Coma Scale score, and intracranial pressure; and drug-related complications.Results: A total of 87 patients were eligible for analysis (n=46 [NC]; n=41 [NM]), and baseline characteristics between groups were similar. Both agents were effective in achieving goal BP during infusion, with 93.5% and 87.8% patients in the NC and NM groups achieving goal, respectively. Fewer additional medications were needed to control BP in the NC group. BP variability was similar and no differences were observed in the mean time to goal BP and mean numbers of dose adjustments between both groups. Interestingly, intracranial pressure declined (P=0.048) during NC administration but increased (P=0.066) after NM treatment. Finally, the incidences of hematoma expansion, neurological deterioration, and adverse drug events were similar in both groups.Conclusion: NM is effective and safe for BP control in patients with ICH.Keywords: nicardipine, blood pressure, intravenous infusion |
| format |
article |
| author |
Li YQ Fang W Tao L Li M Yang YL Gao YF Ge SN Gao L Zhang B Li ZH Zhou W Wang BL Li LH |
| author_facet |
Li YQ Fang W Tao L Li M Yang YL Gao YF Ge SN Gao L Zhang B Li ZH Zhou W Wang BL Li LH |
| author_sort |
Li YQ |
| title |
Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| title_short |
Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| title_full |
Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| title_fullStr |
Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| title_full_unstemmed |
Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| title_sort |
efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/eac07ed38a054824be62e6d2a287f0e9 |
| work_keys_str_mv |
AT liyq efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT fangw efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT taol efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT lim efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT yangyl efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT gaoyf efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT gesn efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT gaol efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT zhangb efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT lizh efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT zhouw efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT wangbl efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage AT lilh efficacyandsafetyofintravenousnimodipineadministrationfortreatmentofhypertensioninnbsppatientswithintracerebralhemorrhage |
| _version_ |
1718403108993761280 |